C-Reactive Protein (CRP) Explained: Understanding High, Low and hs-CRP Blood Test Results

This guide is for general health education only. It does not diagnose infection, autoimmune disease, cardiovascular disease, cancer or any other condition and does not recommend personalised medication or treatment.

A CRP result should be interpreted using the reference interval provided by the laboratory, together with symptoms, medical history, examination findings and other investigations.

Seek appropriate medical assessment rather than relying on CRP alone when there are serious symptoms such as difficulty breathing, chest pain, confusion, severe weakness, persistent high fever, signs of sepsis, severe headache with neck stiffness, rapidly worsening illness or other concerning symptoms.

CRP is one of the most commonly ordered inflammatory blood tests.

It can appear in investigations for:

infection, inflammatory arthritis, abdominal illness, autoimmune conditions, inflammatory bowel disease, postoperative complications, respiratory infections, rheumatological disease, and many other clinical scenarios.

That broad usefulness creates a problem.

Patients often see a result such as:

CRP: 48 mg/L — HIGH

and immediately ask:

“What does 48 mean?”

The number by itself does not provide a diagnosis.

A CRP of 48 mg/L could occur in one person with a respiratory infection, another with an inflammatory arthritis flare, another following surgery, and another with an entirely different inflammatory process.

Gloucestershire Hospitals NHS Foundation Trust describes CRP as a non-specific marker of infection and inflammation and specifically notes that it cannot identify which organ is affected.

That is the fundamental limitation of CRP.

It is powerful because it detects inflammation quickly.

It is limited because inflammation is a biological process shared by hundreds of different conditions.

If the alarm sounds, something may be generating smoke.

But the detector cannot tell you:

whether the problem is burnt toast, an electrical fault, a small kitchen fire, or a major building fire.

The CRP number tells you something about the inflammatory signal.

Clinical assessment identifies the source.

CRP is an acute-phase protein produced predominantly by the liver.

During inflammation, signalling molecules released by immune and other cells stimulate the liver to increase production of several acute-phase proteins, including CRP. North West London Pathology describes CRP as an IL-6-mediated acute-phase reactant that generally rises in proportion to inflammatory responses.

Its physiological role forms part of innate immunity.

CRP can bind to structures exposed on damaged cells and microorganisms and interact with components of the complement system, helping the immune system recognise and clear damaged material.

For everyday clinical interpretation, however, its most important characteristic is not the detailed immunology.

It is this:

CRP rises when inflammatory signalling rises.

That inflammation may be caused by infection.

Or autoimmune disease.

Or tissue damage.

Or surgery.

Or numerous other processes.

CRP reacts substantially faster than some older inflammatory markers.

University Hospitals of North Midlands states that CRP can begin rising approximately 6–12 hours after initiation of an acute-phase response and commonly reaches a peak at around 48 hours.

South Tees Hospitals NHS Foundation Trust similarly describes CRP as a rapidly changing acute-phase marker.

This characteristic creates two important consequences.

1. An early CRP can still be low

Suppose an infection began only a few hours before the blood sample was taken.

CRP may not yet have had enough time to rise substantially.

Therefore:

A normal CRP very early in an illness does not necessarily exclude developing inflammation.

This is one reason serious clinical decisions should never be based on CRP alone. NICE specifically warns against excluding bacterial meningitis solely because CRP, procalcitonin or the white blood cell count is normal.

2. Trends can be highly informative

If treatment is effective or an inflammatory process resolves, CRP can fall relatively quickly.

That means:

CRP 180 → 120 → 55 → 18 mg/L

may be considerably more informative than simply knowing that the latest CRP is 18.

Likewise:

CRP 12 → 28 → 76 → 160

may indicate an evolving inflammatory process that warrants reassessment.

There is no universal reference interval.

Different laboratories use different analytical methods and define their own ranges.

Cambridge University Hospitals currently lists an adult CRP reference range of:

0–6 mg/L

Other UK laboratories commonly use an upper reference limit around 5 mg/L.

The practical rule is:

Use the range printed beside your own result.

A CRP of 6 mg/L could be:

normal in one laboratory, slightly elevated in another.

This is not necessarily a contradiction.

Patients understandably want a table that says:

10 = this disease 50 = that disease 200 = severe infection.

Medicine is not that clean.

Nevertheless, approximate patterns can help explain why different CRP values receive different levels of attention.

Sheffield Laboratory Medicine provides illustrative guidance in which CRP concentrations around 10–40 mg/L can occur with mild inflammation and some viral infections, while concentrations around 40–200 mg/L are seen with more substantial acute inflammation and bacterial infection. However, these ranges overlap substantially between conditions and are not diagnostic thresholds.

A cautious educational framework is therefore:

This framework should not be used as a self-diagnostic tool.

Healio360 Insight The same CRP can mean very different things in different people.

Consider:

Patient A: CRP 65 mg/L Fever, productive cough, low oxygen saturation

Patient B: CRP 65 mg/L Known rheumatoid arthritis with swollen painful joints

Patient C: CRP 65 mg/L Three days after major abdominal surgery

Patient D: CRP 65 mg/L Severe abdominal pain and vomiting

The laboratory number is identical.

The clinical interpretation is not.

Infection is one of the most important causes of CRP elevation, but high CRP does not equal infection.

CRP may rise in response to:

bacterial infection, viral infection, inflammatory arthritis, vasculitis, autoimmune disease, tissue injury, surgery, myocardial injury, malignancy, trauma, and other inflammatory processes.

The higher the CRP, the more likely a substantial inflammatory process becomes.

But CRP cannot reliably identify which process is responsible.

Not reliably on its own.

Bacterial infections frequently produce stronger CRP responses than many viral infections.

That is a useful statistical tendency.

It is not a biological law.

Some viral illnesses can produce substantial CRP elevations, while some bacterial infections—particularly early, localised or partially treated infections—may have relatively modest CRP levels.

NICE therefore uses CRP only as one component of clinical decision-making in selected respiratory infections.

A particularly important NICE example

For people over 16 with suspected lower respiratory tract infection, when clinical assessment has not clarified whether antibiotics are needed, NICE recommends considering point-of-care CRP testing.

Its guidance is:

This table is frequently misused online.

It does not mean:

“Anyone with CRP 110 has a bacterial infection.”

It means that in a specific adult lower-respiratory-tract-infection pathway after clinical assessment, CRP can support antibiotic decision-making.

The same thresholds should not be blindly applied to appendicitis, urinary infection, arthritis, postoperative inflammation, meningitis or every other clinical setting.

Yes.

Possible reasons include:

very early testing, localised infection, particular organisms, variation in individual inflammatory response, immune suppression, partially treated infection, or disease processes that produce relatively modest CRP responses.

NICE specifically states that bacterial meningitis should not be excluded solely because CRP, procalcitonin or white cell count is normal.

This is a crucial principle:

A normal inflammatory marker cannot overrule a strongly concerning clinical picture.

CRP may be substantially elevated in sepsis, but it does not diagnose sepsis.

Sepsis is a clinical syndrome caused by a dysregulated response to infection resulting in organ dysfunction.

Assessment therefore depends on clinical features and physiological measurements such as:

blood pressure, respiratory status, mental state, temperature, heart rate, urine output, lactate and other investigations.

CRP may support the overall picture and can be useful for monitoring trends, but it should never be interpreted as a standalone “sepsis test.” NHS pathology guidance similarly advises interpreting CRP alongside clinical assessment and other markers.

CRP is frequently measured in inflammatory autoimmune diseases.

Examples include:

rheumatoid arthritis, polymyalgia rheumatica, some forms of vasculitis, inflammatory bowel disease, inflammatory connective-tissue disorders.

In rheumatoid arthritis, NICE recommends CRP measurement alongside composite disease-activity assessment during active treatment until remission or low disease activity is achieved.

However, CRP response differs between diseases and between individuals.

A normal CRP does not automatically exclude autoimmune disease.

NICE's rheumatoid arthritis guidance is particularly instructive: people with persistent synovitis may require urgent specialist referral even when the acute-phase response is normal.

CRP can help quantify inflammatory activity in established rheumatoid arthritis.

NICE recommends measuring CRP together with a validated disease activity score such as DAS28 monthly in specialist care while active RA is being treated toward remission or low disease activity.

But CRP alone cannot diagnose rheumatoid arthritis.

Diagnosis incorporates:

symptoms, examination, joint distribution, rheumatoid factor, anti-CCP antibodies, imaging, and specialist assessment.

Some people with genuine active RA can have normal CRP.

Therefore:

normal CRP ≠ no rheumatoid arthritis

and:

high CRP ≠ rheumatoid arthritis

CRP and ESR are commonly measured when polymyalgia rheumatica (PMR) is suspected.

The NHS states that both tests can be used to assess inflammation and notes that PMR is less likely when both ESR and CRP are normal.

However, neither marker is specific for PMR.

The diagnosis still depends on:

age, characteristic shoulder and hip symptoms, symptom duration, exclusion of mimicking conditions, and response to appropriate clinical management.

CRP and the erythrocyte sedimentation rate (ESR) are both used as inflammatory markers.

They are not interchangeable.

CRP

CRP measures the concentration of a specific acute-phase protein.

It:

responds relatively rapidly, can rise and fall over hours to days, is less directly affected by red blood cell characteristics. ESR

ESR measures how quickly red blood cells settle in a vertical tube over a defined period.

Its value is influenced not only by inflammation but also by:

age, sex, anaemia, changes in plasma proteins, red-cell characteristics.

Gloucestershire Hospitals NHS Foundation Trust describes CRP as a more sensitive and rapidly responding indicator than ESR or plasma viscosity for many purposes.

At the same time, ESR remains useful in selected conditions such as polymyalgia rheumatica and giant-cell arteritis.

The two tests have different biological behaviour.

This distinction creates a great deal of confusion.

Standard CRP

Designed primarily to detect concentrations relevant to:

acute inflammation, infection, inflammatory disease, tissue injury. High-sensitivity CRP — hs-CRP

Uses an assay capable of measuring CRP accurately at much lower concentrations.

It is primarily useful for evaluating low-grade systemic inflammation related to cardiovascular risk in selected patients.

Both tests measure the same protein.

The difference is analytical sensitivity and clinical purpose.

Atherosclerosis is now understood not simply as cholesterol deposition but as a disease involving lipid accumulation, vascular injury and inflammation.

Higher hs-CRP concentrations are associated with greater risk of cardiovascular events.

The American Heart Association describes hs-CRP as a marker that can provide additional cardiovascular-risk information beyond conventional risk factors in selected individuals.

In March 2026, updated ACC/AHA dyslipidaemia guidance identified:

hs-CRP ≥2 mg/L on more than one occasion, if measured

as a risk-enhancing factor that can refine assessment in selected people whose cardiovascular risk remains uncertain.

That does not make hs-CRP a replacement for:

LDL cholesterol, blood pressure, smoking history, diabetes assessment, kidney function, family history, age, or validated cardiovascular-risk calculators.

It is an additional risk modifier.

Historically, hs-CRP has often been described using approximate categories:

Modern guidelines increasingly focus less on these categories and more on overall cardiovascular risk, with persistent hs-CRP ≥2 mg/L being particularly relevant as a risk-enhancing factor in the 2026 ACC/AHA framework.

These are cardiovascular-risk concepts.

They should not be used to interpret acute infection.

Suppose someone develops influenza and has:

hs-CRP: 18 mg/L

Using a cardiovascular hs-CRP table might incorrectly suggest “extremely high cardiovascular inflammation.”

The problem is that acute infection can temporarily increase CRP substantially.

The AHA therefore recommends interpreting hs-CRP in a clinically stable context, and persistent elevation rather than a single value during an acute inflammatory illness is more meaningful for cardiovascular risk assessment. The 2026 guideline specifically refers to ≥2 mg/L on more than one occasion.

CRP 8 mg/L during an infection investigation and hs-CRP 8 mg/L during stable cardiovascular risk assessment are technically measurements of the same protein—but the clinical interpretation is completely different.

hs-CRP is best understood clinically as a biomarker of inflammatory risk, rather than simply assuming the CRP protein itself is the direct cause of atherosclerotic events.

Inflammation is deeply involved in atherosclerosis, but cardiovascular biology is more complex than “high CRP causes heart attacks.”

The practical role of hs-CRP is therefore risk stratification.

Recent European Society of Cardiology commentary similarly describes hs-CRP as potentially useful alongside conventional cardiovascular risk factors for identifying persistent inflammatory risk.

This is more complicated than simply trying to “treat the CRP number.”

Some therapies that reduce cardiovascular events also reduce hs-CRP, including statins.

Clinical trials such as JUPITER enrolled people with LDL cholesterol below traditional treatment thresholds but hs-CRP above 2 mg/L and demonstrated cardiovascular benefit from statin therapy in the trial population.

However, this does not mean:

“Everyone with hs-CRP 2.1 should take a statin.”

Current prevention decisions should incorporate overall cardiovascular risk, lipid levels, age, comorbidities, other risk enhancers and shared clinical decision-making.

Low-grade elevations may occur with many conditions and exposures.

Possible contributors include:

recent infection, chronic inflammatory conditions, obesity and metabolic inflammation, smoking, periodontal inflammation, tissue injury, cardiovascular disease, chronic inflammatory disease.

Because the causes are numerous, a mildly elevated CRP is particularly poor as a standalone diagnostic test.

Gloucestershire Hospitals specifically advises that CRP should not be used as a general screening test for inflammation.

This is a useful warning against commercial “inflammation scores” that treat a single CRP result as an overall measure of health.

Adipose tissue is metabolically active and can contribute to low-grade systemic inflammatory signalling.

People with higher levels of adiposity therefore often have modestly elevated hs-CRP.

This association matters particularly when hs-CRP is being used in cardiovascular-risk assessment because obesity itself is already linked to metabolic and cardiovascular risk.

An elevated hs-CRP in this context should therefore be considered part of the wider risk profile rather than interpreted as evidence of a hidden infection.

The AHA's cardiovascular guidance emphasises integration of hs-CRP with conventional risk factors rather than interpretation in isolation.

Surgery causes tissue injury and activates an inflammatory response.

CRP commonly rises after major operations even when no infection is present. NHS pathology sources include surgery and trauma among recognised causes of increased CRP.

Postoperative clinicians are therefore often more interested in the trajectory than the existence of an initial rise.

An expected rise followed by decline may fit normal postoperative inflammation.

A persistently high or secondary rise, particularly with fever, worsening pain or other concerning findings, may prompt investigation for complications.

The exact significance depends heavily on the operation and clinical circumstances.

Significant tissue injury can increase inflammatory markers.

Minor everyday exercise is unlikely to create CRP levels resembling severe bacterial infection, but strenuous prolonged exercise or substantial muscle damage can produce temporary inflammatory changes.

Trauma is likewise a recognised cause of elevated CRP.

This reinforces the importance of telling the clinician what was happening around the time of the blood test.

Some cancers can be associated with systemic inflammation and elevated CRP.

However:

CRP is not a cancer screening test.

An elevated CRP is far too nonspecific to tell whether cancer is present.

Infection and inflammatory disease are far more common explanations in many clinical settings.

CRP may sometimes be used as part of prognostic assessment in established malignancy, but an isolated high CRP cannot diagnose cancer.

NHS pathology guidance lists neoplastic processes among many causes capable of producing an acute-phase response.

Yes.

A mild elevation may be discovered incidentally.

Possible explanations include:

resolving recent illness, chronic inflammatory disease, low-grade metabolic inflammation, smoking, subclinical infection, another inflammatory process, or normal biological variation around the laboratory cutoff.

Because CRP is nonspecific, investigating a completely asymptomatic person solely because of a very small elevation can sometimes generate unnecessary testing.

This is why NHS laboratory guidance explicitly advises against using CRP as a general screening test for inflammation.

Yes.

Symptoms are not generated by CRP itself.

A person can have significant illness before CRP has risen, or a disease may not trigger a strong CRP response.

Some serious conditions also cause symptoms through mechanisms unrelated to systemic inflammation.

Therefore:

Never use a low CRP as permission to ignore severe or worsening symptoms.

NICE's meningitis guidance provides a particularly important example, stating that normal CRP should not be used alone to rule out bacterial meningitis.

This question needs reframing.

CRP is usually a marker, not the disease itself.

If CRP is elevated because of pneumonia, the goal is not to lower the CRP directly.

The goal is to appropriately manage the pneumonia.

If CRP is elevated because of rheumatoid arthritis, management targets the inflammatory disease.

If hs-CRP is persistently elevated in someone undergoing cardiovascular risk assessment, the goal is comprehensive risk reduction—not chasing one laboratory number.

Trying to lower CRP with supplements without understanding why it is elevated is the biological equivalent of silencing a fire alarm without looking for smoke.

The number is never the only consideration.

Faster medical assessment may be appropriate when CRP elevation occurs alongside:

difficulty breathing, low oxygen levels, severe or persistent fever, confusion, severe drowsiness, fainting, very low blood pressure, rapidly worsening symptoms, severe abdominal pain, a painful swollen joint with fever, severe headache or neck stiffness, new neurological symptoms, signs of severe infection, or significant deterioration following surgery.

Equally, concerning symptoms should be assessed even when CRP is normal because early or particular diseases may not generate an immediate CRP response. NICE specifically cautions against excluding serious bacterial meningitis solely because inflammatory markers are normal.

Blood Tests & Biomarkers HbA1c Explained: Understanding Your Blood Sugar Over Time Ferritin Explained: Understanding Your Iron Stores Vitamin B12 Explained Vitamin D Explained Thyroid Function Tests Explained Liver Function Tests Explained Complete Blood Count Explained White Blood Cell Count Explained Neutrophils Explained ESR Explained: Understanding Your Sedimentation Rate Procalcitonin Explained Platelets Explained Creatinine & eGFR Explained Cholesterol & Lipid Profile Explained Cardiovascular & Metabolic Health LDL Cholesterol Explained ApoB Explained Lipoprotein(a) Explained Cardiovascular Risk Explained Metabolic Syndrome Explained HbA1c and Prediabetes Explained Understanding Medical Reports What Does “Unremarkable” Mean on a Scan? What Does “Mild Degenerative Changes” Mean? What Does “Clinical Correlation Recommended” Mean?

One CRP result is a snapshot. Inflammation is a process.

Seeing:

CRP: 72 mg/L

may understandably create anxiety.

But without context, it tells an incomplete story.

A longitudinal view might instead reveal:

CRP 6 → 28 → 96 → 72 → 31 → 8

White blood cells 7.2 → 10.5 → 14.1 → 11.8 → 8.9 → 7.4

Temperature 37.0 → 38.5 → 39.1 → 38.0 → 37.2 → 36.9°C

That connected picture tells a much more meaningful story than a single red number.

Or cardiovascular monitoring might reveal:

hs-CRP 2.7 → 2.4 → 2.6 mg/L

alongside:

LDL cholesterol 3.8 → 3.4 → 3.0 mmol/L

HbA1c 41 → 43 → 44 mmol/mol

Blood pressure 132/82 → 138/84 → 136/83 mmHg

Again, the value comes from connecting the markers rather than treating hs-CRP as a standalone health score.

Healio360 helps bring those pieces together.

Upload medical reports, organise biomarkers chronologically and understand changes in plain language so that isolated laboratory values become part of a longitudinal health record.

Instead of asking only:

“Why is my CRP high?”

you can begin asking:

“When did it rise?”

“Is it rising or falling?”

“What happened to my white cell count at the same time?”

“Was I unwell when this sample was taken?”

“Is this standard CRP or hs-CRP?”

“Has a cardiovascular hs-CRP elevation been persistent?”

“Does the result fit the rest of my medical history?”

Turn fragmented health information into a clearer, connected medical story.

Healio360 provides educational health information and organisational tools. It does not diagnose infection, inflammatory disease or cardiovascular disease, replace professional medical assessment, or provide personalised treatment recommendations.